T Lymphocyte Costimulation Activity Blockade [PE] - N0000182829
Pharmacologic Class Information
Pharmacologic Code | N0000182829 |
Pharmacologic Name | T Lymphocyte Costimulation Activity Blockade |
Pharmacologic Concept | Physiologic Effects - [PE] |
Pharmacologic Concept Description | This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept. |
NDC Products with T Lymphocyte Costimulation Activity Blockade
The table contains 1 products whose active ingredient are classified under the same pharmacologic class T Lymphocyte Costimulation Activity Blockade [PE].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0003-0371 | Nulojix | Non-Proprietary Name: Belatacept | Injection, Powder, Lyophilized, For Solution | Intravenous | E.r. Squibb & Sons, L.l.c. | ACTIVE |